Saxenda vs Trulicity
Quick Facts
- Type: GLP-1
- FDA Approval: Saxenda (2014), Trulicity (2014)
- Frequency: Once daily
Weight Loss Data
- Saxenda: 5-10% in 56 weeks
- Trulicity: 2-6% in 52 weeks
Primary Uses
- •Weight Management
- •Obesity Treatment
- •Type 2 Diabetes
- •Cardiovascular Risk Reduction
Medication Overview
Saxenda
GLP-1Basic Information
- Generic Name: liraglutide
- Manufacturer: Novo Nordisk
- FDA Approval: 2014
Key Benefits
- ✓Established weight loss medication
- ✓Well-studied safety profile
- ✓May improve cardiovascular risk factors
- ✓Flexible dosing schedule
Trulicity
GLP-1Basic Information
- Generic Name: dulaglutide
- Manufacturer: Eli Lilly
- FDA Approval: 2014
Key Benefits
- ✓Once-weekly dosing
- ✓Ready-to-use pen
- ✓Cardiovascular benefits
- ✓No dose titration required for standard dose
Dosing Information
| Dosing Details | Saxenda | Trulicity |
|---|---|---|
| Starting Dose | 0.6mg | 0.75mg |
| Maintenance Dose | 3.0mg | 1.5mg |
| Maximum Dose | 3.0mg | 4.5mg |
| Schedule | Inject once daily at any time of day | Inject once weekly at any time of day |
| Titration | Start with 0.6mg, increase by 0.6mg weekly until reaching 3.0mg | Start with 0.75mg, can increase to 1.5mg after 4 weeks if needed |
Side Effects
Saxenda
- •Nausea
- •Diarrhea
- •Constipation
- •Vomiting
- •Injection Site Reactions
- •Low Blood Sugar
Trulicity
- •Nausea
- •Diarrhea
- •Vomiting
- •Abdominal Pain
- •Decreased Appetite
- •Indigestion
Practical Information
Saxenda
Storage & Handling
- Storage: Refrigerate until first use, then can be stored at room temperature for up to 30 days
- Needle Info: Comes with NovoFine® needles
Insurance & Coverage
Variable coverage for weight management, often requires prior authorization
Clinical Results
- Weight Loss: 5-10%
- Study Duration: 56 weeks
- Study: SCALE clinical trial program
Trulicity
Storage & Handling
- Storage: Refrigerate until first use, then can be stored at room temperature for up to 14 days
- Needle Info: Comes with attached hidden needle
Insurance & Coverage
Generally well-covered for diabetes treatment
Clinical Results
- Weight Loss: 2-6%
- Study Duration: 52 weeks
- Study: AWARD clinical trial program
Medical Disclaimer: This comparison is for informational purposes only and should not replace professional medical advice. Always consult with your healthcare provider about which medication is right for you. Treatment decisions should be based on your individual medical needs and circumstances.
Track Your GLP-1 Journey with ShotWise
Get personalized dose tracking, side effect monitoring, and weight loss progress tracking all in one place. Join thousands of others managing their GLP-1 medications effectively.
Download ShotWise